Dow Jones

39 872,99

0,17%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

BIVI

BioVie (BIVI)

BioVie Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:BIVI

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
14/05/2024	23h06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIVI	BioVie Inc
14/03/2024	10h45	PR Newswire (US)	The Gross Law Firm Notifies Shareholders of BioVie Inc. (BIVI) of a Class Action Lawsuit and an Upcoming Deadline	NASDAQ:BIVI	BioVie Inc
11/03/2024	22h00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIVI	BioVie Inc
11/03/2024	10h45	PR Newswire (US)	BioVie Inc. Class Action: The Gross Law Firm Reminds BioVie Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - BIVI	NASDAQ:BIVI	BioVie Inc
07/03/2024	11h45	PR Newswire (US)	Contact The Gross Law Firm by March 19, 2024 Deadline to Join Class Action Against BioVie Inc.(BIVI)	NASDAQ:BIVI	BioVie Inc
04/03/2024	23h28	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:BIVI	BioVie Inc
04/03/2024	23h28	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BIVI	BioVie Inc
26/02/2024	11h45	PR Newswire (US)	The Gross Law Firm Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BIVI	NASDAQ:BIVI	BioVie Inc
09/02/2024	11h45	PR Newswire (US)	The Gross Law Firm Reminds BioVie Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - BIVI	NASDAQ:BIVI	BioVie Inc
02/02/2024	11h45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioVie Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: BIVI)	NASDAQ:BIVI	BioVie Inc
19/01/2024	23h00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BIVI	BioVie Inc
13/12/2023	23h15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIVI	BioVie Inc
29/09/2023	23h20	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BIVI	BioVie Inc
29/08/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BIVI	BioVie Inc
18/08/2023	22h31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BIVI	BioVie Inc
16/08/2023	23h30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BIVI	BioVie Inc
26/06/2023	22h07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BIVI	BioVie Inc
12/05/2023	23h17	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIVI	BioVie Inc
14/04/2023	23h16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:BIVI	BioVie Inc
11/04/2023	12h04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BIVI	BioVie Inc
07/04/2023	12h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIVI	BioVie Inc
07/04/2023	12h01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:BIVI	BioVie Inc
10/03/2023	23h16	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:BIVI	BioVie Inc
12/12/2022	14h01	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:BIVI	BioVie Inc
06/12/2022	11h21	TipRanks	BioVie (NASDAQ:BIVI) Stock Surges on Positive Results from Two Phase 2 Trials	NASDAQ:BIVI	BioVie Inc
10/11/2022	23h19	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:BIVI	BioVie Inc
30/09/2022	23h01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIVI	BioVie Inc
28/09/2022	22h35	TipRanks	EF Hutton Sticks to Its Buy Rating for BioVie (BIVI)	NASDAQ:BIVI	BioVie Inc
27/09/2022	23h17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIVI	BioVie Inc
12/09/2022	13h25	TipRanks	BioVie (BIVI) Gets a Buy from B.Riley Financial	NASDAQ:BIVI	BioVie Inc